Literature DB >> 22108839

The toxicology of bath salts: a review of synthetic cathinones.

Jane M Prosser1, Lewis S Nelson.   

Abstract

Synthetic cathinones have recently emerged and grown to be popular drugs of abuse. Their dramatic increase has resulted in part from sensationalized media attention as well as widespread availability on the Internet. They are often considered "legal highs" and sold as "bath salts" or "plant food" and labeled "not for human consumption" to circumvent drug abuse legislation. Cathinone is a naturally occurring beta-ketone amphetamine analogue found in the leaves of the Catha edulis plant. Synthetic cathinones are derivatives of this compound. Those that are being used as drugs of abuse include butylone, dimethylcathinone, ethcathinone, ethylone, 3- and 4-fluoromethcathinone, mephedrone, methedrone, methylenedioxypyrovalerone (MDPV), methylone, and pyrovalerone. Synthetic cathinones are phenylalkylamines derivatives, and are often termed "bk-amphetamines" for the beta-ketone moiety. They may possess both amphetamine-like properties and the ability to modulate serotonin, causing distinct psychoactive effects. Desired effects reported by users of synthetic cathinones include increased energy, empathy, openness, and increased libido. Cardiac, psychiatric, and neurological signs and symptoms are the most common adverse effects reported in synthetic cathinone users who require medical care. Deaths associated with use of these compounds have been reported. Exposure to and use of synthetic cathinones are becoming increasingly popular despite a lack of scientific research and understanding of the potential harms of these substances. The clinical similarities to amphetamines and MDMA specifically are predictable based on the chemical structure of this class of agents. More work is necessary to understand the mechanisms of action, toxicokinetics, toxicodynamics, metabolism, clinical and psychological effects as well as the potential for addiction and withdrawal of these agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22108839      PMCID: PMC3550219          DOI: 10.1007/s13181-011-0193-z

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  52 in total

1.  Headshop heartache: acute mephedrone 'meow' myocarditis.

Authors:  Patrick J Nicholson; Martin J Quinn; Jonathan D Dodd
Journal:  Heart       Date:  2010-11-09       Impact factor: 5.994

2.  Second generation mephedrone. The confusing case of NRG-1.

Authors:  Simon D Brandt; Harry R Sumnall; Fiona Measham; Jon Cole
Journal:  BMJ       Date:  2010-07-06

3.  Gas chromatography/mass spectrometry determination of mephedrone in drug seizures after derivatization with 2,2,2-trichloroethyl chloroformate.

Authors:  Giampietro Frison; Maria Gregio; Luca Zamengo; Flavio Zancanaro; Samuela Frasson; Rocco Sciarrone
Journal:  Rapid Commun Mass Spectrom       Date:  2011-01-30       Impact factor: 2.419

4.  Effects of pyrovalerone on peripheral noradrenergic mechanisms.

Authors:  A Servin; J P Fauquet; C Jacquot; J R Rapin
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.

Authors:  J Kehr; F Ichinose; S Yoshitake; M Goiny; T Sievertsson; F Nyberg; T Yoshitake
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  The metabolism of pyrovalerone hydrochloride.

Authors:  W Michaelis; J H Russel; O Schindler
Journal:  J Med Chem       Date:  1970-05       Impact factor: 7.446

7.  Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.

Authors:  D M Wood; S L Greene; P I Dargan
Journal:  Emerg Med J       Date:  2010-06-26       Impact factor: 2.740

8.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

9.  The disposition into hair of new designer drugs; methylone, MBDB and methcathinone.

Authors:  Ruri Kikura-Hanajiri; Maiko Kawamura; Kazuhiro Saisho; Yukio Kodama; Yukihiro Goda
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-05-29       Impact factor: 3.205

10.  Methylone and monoamine transporters: correlation with toxicity.

Authors:  Chiharu Sogawa; Norio Sogawa; Kazumi Ohyama; Ruri Kikura-Hanajiri; Yukihiro Goda; Ichiro Sora; Shigeo Kitayama
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more
  130 in total

1.  Emerging drugs of abuse: what was new yesterday is new today.

Authors:  Mark B Mycyk
Journal:  J Med Toxicol       Date:  2012-03

Review 2.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

Review 3.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

4.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

5.  Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Authors:  Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-02-12       Impact factor: 3.533

6.  Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Authors:  Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

7.  Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice.

Authors:  Azizi Ray; Neha Milind Chitre; Cedrick Maceo Daphney; Bruce E Blough; Clinton E Canal; Kevin Sean Murnane
Journal:  Psychopharmacology (Berl)       Date:  2018-10-01       Impact factor: 4.530

8.  Acute kidney injury requiring haemodialysis following ingestion of mephedrone.

Authors:  Rhys Rhidian; Adarsh Babu
Journal:  BMJ Case Rep       Date:  2013-03-01

9.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

10.  Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences.

Authors:  Richard A Glennon; Małgorzata Dukat
Journal:  Ann Forensic Res Anal       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.